Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001623632-18-000209
Filing Date
2018-02-14
Accepted
2018-02-14 10:34:51
Documents
3

Document Format Files

Seq Description Document Type Size
1 form.htm SC 13G 102006
2 GRAPHIC image_001.jpg GRAPHIC 64828
3 GRAPHIC image_002.jpg GRAPHIC 60203
  Complete submission text file 0001623632-18-000209.txt   276158
Mailing Address FEDERATED INVESTORS TOWER 1001 LIBERTY AVENUE PITTSBURGH PA 15222
Business Address FEDERATED INVESTORS TOWER 1001 LIBERTY AVENUE PITTSBURGH PA 15222 4122881900
FEDERATED INVESTORS INC /PA/ (Filed by) CIK: 0001056288 (see all company filings)

EIN.: 251111467 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Subject) CIK: 0001609351 (see all company filings)

EIN.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88577 | Film No.: 18608518
SIC: 2836 Biological Products, (No Diagnostic Substances)